Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$35.55 - $43.57 $8,425 - $10,326
237 Added 21.58%
1,335 $57,000
Q3 2023

Oct 25, 2023

BUY
$39.13 - $47.24 $5,086 - $6,141
130 Added 13.43%
1,098 $44,000
Q2 2023

Jul 28, 2023

BUY
$43.93 - $46.76 $395 - $420
9 Added 0.94%
968 $43,000
Q1 2023

Apr 26, 2023

BUY
$45.29 - $50.76 $2,853 - $3,197
63 Added 7.03%
959 $44,000
Q4 2022

Jan 24, 2023

SELL
$41.91 - $50.48 $5,741 - $6,915
-137 Reduced 13.26%
896 $0
Q3 2022

Nov 10, 2022

SELL
$40.9 - $50.42 $81 - $100
-2 Reduced 0.19%
1,033 $43,000
Q2 2022

Aug 01, 2022

BUY
$42.98 - $49.77 $1,074 - $1,244
25 Added 2.48%
1,035 $49,000
Q1 2022

Apr 21, 2022

SELL
$42.23 - $54.3 $6,292 - $8,090
-149 Reduced 12.86%
1,010 $49,000
Q4 2021

Jan 18, 2022

SELL
$50.62 - $56.47 $809 - $903
-16 Reduced 1.36%
1,159 $64,000
Q3 2021

Nov 05, 2021

BUY
$46.55 - $56.83 $3,398 - $4,148
73 Added 6.62%
1,175 $61,000
Q2 2021

Jul 27, 2021

SELL
$46.28 - $52.75 $5,137 - $5,855
-111 Reduced 9.15%
1,102 $53,000
Q1 2021

Apr 28, 2021

BUY
$46.25 - $56.02 $8,741 - $10,587
189 Added 18.46%
1,213 $59,000
Q4 2020

Jan 27, 2021

BUY
$46.09 - $54.74 $46 - $54
1 Added 0.1%
1,024 $54,000
Q3 2020

Nov 03, 2020

BUY
$42.51 - $52.42 $1,402 - $1,729
33 Added 3.33%
1,023 $53,000
Q2 2020

Jul 27, 2020

BUY
$39.49 - $44.36 $5,568 - $6,254
141 Added 16.61%
990 $42,000
Q1 2020

Apr 22, 2020

SELL
$33.17 - $41.6 $6,932 - $8,694
-209 Reduced 19.75%
849 $35,000
Q4 2019

Jan 27, 2020

BUY
$25.41 - $43.1 $9,757 - $16,550
384 Added 56.97%
1,058 $36,000
Q3 2019

Oct 31, 2019

SELL
$32.73 - $40.81 $3,862 - $4,815
-118 Reduced 14.9%
674 $22,000
Q2 2019

Jul 24, 2019

BUY
$35.73 - $41.39 $2,179 - $2,524
61 Added 8.34%
792 $32,000
Q4 2018

Feb 07, 2019

BUY
$32.65 - $37.95 $23,867 - $27,741
731 New
731 $25,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.2B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.